M&A Deal Summary

Hologic Acquires Gen-Probe

On August 1, 2012, Hologic acquired medical products company Gen-Probe for 3.8B USD

Acquisition Highlights
  • This is Hologic’s 12th transaction in the Medical Products sector.
  • This is Hologic’s 2nd largest (disclosed) transaction.
  • This is Hologic’s 10th transaction in the United States.
  • This is Hologic’s 3rd transaction in California.

M&A Deal Summary
Date 2012-08-01
Target Gen-Probe
Sector Medical Products
Buyer(s) Hologic
Deal Type Add-on Acquisition
Deal Value 3.8B USD
Advisor(s) Morgan Stanley (Financial)
Cooley (Legal)

Target

Gen-Probe

San Diego, California, United States
Gen-Probe, Inc., is a provider in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hologic

Marlborough, Massachusetts, United States
Category Company
Founded 1985
Sector Medical Products
Employees6,944
Revenue 4.0B USD (2023)
DESCRIPTION
Hologic's corporate headquarters in Marlborough, Massachusetts.
Hologic's corporate headquarters in Marlborough, Massachusetts.

Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 13 of 25
Sector (Medical Products) 12 of 19
Type (Add-on Acquisition) 12 of 23
State (California) 3 of 5
Country (United States) 10 of 18
Year (2012) 1 of 1
Size (of disclosed) 2 of 24
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-06-01 Beijing TCT Medical Technology

Beijing, China

Beijing TCT Medical Technology Co.,Ltd. is a high-tech medical equipment and supplies importer focusing on women health diagnosis and treatment, who enjoys over 30% of share in cervical cancer screening market in China. Company is a exclusive distributor of Cytyc Corp and successfully introduced ThinPrep cytology product into China.

Buy $135M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-03 Hologic - LIFECODES business

United States

Hologic - LIFECODES business includes transplantation diagnostics. LIFECODES sells molecular and antibody-based assays in the markets of transplant diagnostics, specialty coagulation and transfusion medicine.

Sell $85M
Mergr

Product

Company

Legal